NARATRIPTAN

NARATRIPTAN was reported 1403 times

NARATRIPTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPLEMENT FACTOR C1 DECREASED 1 0.0833
1 POSTNATAL GROWTH RESTRICTION 6 0.0458
2 ACQUIRED PLAGIOCEPHALY 1 0.0270
3 CARDIAC ASTHMA 4 0.0267
4 SCLERODACTYLIA 2 0.0256
5 HERPES SIMPLEX REACTIVATION 8 0.0210
6 BRACHYDACTYLY 4 0.0203
7 ATRIAL APPENDAGE CLOSURE 1 0.0200
8 CEREBRAL VASOCONSTRICTION 14 0.0189
9 HYPERCHROMIC ANAEMIA 2 0.0182
10 DERMOID CYST 6 0.0180
11 GINGIVAL INFLAMMATION 3 0.0159
12 EAR CANAL STENOSIS 1 0.0156
13 CHLOASMA 6 0.0129
14 GINGIVAL CYST 1 0.0127
15 GINGIVAL INJURY 3 0.0122
16 ANTERIOR SPINAL ARTERY SYNDROME 1 0.0119
17 ACUTE VESTIBULAR SYNDROME 1 0.0118
18 SPINAL CORD INFARCTION 5 0.0113
19 PLAGIOCEPHALY 5 0.0100
20 DYSPHASIA 4 0.0086
21 CONSCIOUSNESS FLUCTUATING 8 0.0077
22 NEOVASCULARISATION 2 0.0076
23 OPISTHOTONUS 6 0.0075
24 ASYMPTOMATIC BACTERIURIA 1 0.0074
25 BREAST ULCERATION 1 0.0072
26 PRETERM PREMATURE RUPTURE OF MEMBRANES 8 0.0067
27 HELLP SYNDROME 4 0.0065
28 MUSCLE TONE DISORDER 2 0.0064
29 BREAST CELLULITIS 2 0.0063
30 PIGMENTARY MACULOPATHY 3 0.0062
31 FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD 1 0.0061
32 MYOSCLEROSIS 2 0.0054
33 OBSESSIVE-COMPULSIVE SYMPTOM 2 0.0054
34 HERNIA HIATUS REPAIR 1 0.0049
35 XEROSIS 6 0.0048
36 MEDICATION OVERUSE HEADACHE 4 0.0047
37 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
38 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
39 LACTATION DISORDER 2 0.0041
40 LYMPHADENECTOMY 4 0.0041
41 FINE MOTOR DELAY 1 0.0039
42 DRAIN PLACEMENT 1 0.0039
43 GASTROINTESTINAL PROCEDURAL COMPLICATION 1 0.0037
44 GONORRHOEA 1 0.0037
45 RESPIRATORY DISORDER NEONATAL 6 0.0037
46 ANGIOGRAM 1 0.0036
47 DAIRY INTOLERANCE 1 0.0036
48 OPHTHALMIC HERPES SIMPLEX 2 0.0035
49 NERVE BLOCK 2 0.0034
50 BREAST ENGORGEMENT 1 0.0034
51 FEMORAL ARTERY OCCLUSION 1 0.0032
52 TELANGIECTASIA 3 0.0031
53 BROW PTOSIS 2 0.0030
54 COAGULATION TIME SHORTENED 1 0.0030
55 HEMIPLEGIC MIGRAINE 1 0.0029
56 ANION GAP DECREASED 1 0.0029
57 OVERLAP SYNDROME 2 0.0029
58 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
59 CHEMICAL BURN 3 0.0026
60 FAT TISSUE DECREASED 1 0.0026
61 GRIMACING 2 0.0026
62 ASYMPTOMATIC COVID-19 1 0.0025
63 BLIGHTED OVUM 1 0.0025
64 UNDERWEIGHT 5 0.0025
65 HIGH RISK PREGNANCY 1 0.0025
66 INTRA-ABDOMINAL HAEMATOMA 3 0.0024
67 BLOOD UREA DECREASED 3 0.0024
68 FISTULA OF SMALL INTESTINE 1 0.0024
69 DENTAL DISCOMFORT 2 0.0024
70 ABDOMINAL LYMPHADENOPATHY 2 0.0023
71 HYPOVITAMINOSIS 3 0.0023
72 HOMELESS 1 0.0022
73 RED BLOOD CELL SEDIMENTATION RATE INCREASED 24 0.0022
74 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
75 AIR EMBOLISM 1 0.0021
76 RETINAL VEIN OCCLUSION 6 0.0021
77 EXOSTOSIS OF JAW 1 0.0020
78 SMALL FOR DATES BABY 10 0.0020
79 CORNEAL SCAR 1 0.0020
80 APPLICATION SITE INFECTION 1 0.0020
81 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
82 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
83 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
84 ANAL STENOSIS 1 0.0019
85 SOMATIC SYMPTOM DISORDER 2 0.0019
86 PATHOLOGICAL GAMBLING 3 0.0018
87 GENITAL DISCOMFORT 1 0.0018
88 ENDOMETRIAL THICKENING 1 0.0018
89 BODY TINEA 1 0.0018
90 DYSPRAXIA 1 0.0018
91 SPLEEN DISORDER 3 0.0018
92 WOUND COMPLICATION 6 0.0017
93 HYPERTENSIVE EMERGENCY 2 0.0017
94 MACULOPATHY 6 0.0017
95 OESOPHAGITIS 18 0.0016
96 AUTOIMMUNE COLITIS 1 0.0016
97 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
98 SLOW RESPONSE TO STIMULI 2 0.0015
99 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
100 CATARACT NUCLEAR 1 0.0015
101 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
102 CYST RUPTURE 1 0.0015
103 LYMPHOCYTE COUNT DECREASED 26 0.0015
104 OSTEOLYSIS 3 0.0015
105 CLUSTER HEADACHE 2 0.0015
106 EPISCLERITIS 1 0.0014
107 PREMATURE LABOUR 8 0.0014
108 GLUTEN SENSITIVITY 2 0.0014
109 APPENDICECTOMY 5 0.0014
110 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
111 SUBARACHNOID HAEMORRHAGE 14 0.0014
112 BLUNTED AFFECT 1 0.0014
113 ANKLE OPERATION 2 0.0014
114 CALCINOSIS 3 0.0013
115 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
116 TALIPES 4 0.0013
117 FOREIGN BODY IN UROGENITAL TRACT 1 0.0013
118 SUBSTANCE USE 2 0.0013
119 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
120 MIGRAINE 120 0.0013
121 HEAT EXHAUSTION 1 0.0012
122 CHEMICAL INJURY 1 0.0012
123 TONSILLECTOMY 2 0.0012
124 HEPATITIS A 1 0.0012
125 SEIZURE LIKE PHENOMENA 2 0.0012
126 ALLERGIC SINUSITIS 1 0.0012
127 LACK OF INJECTION SITE ROTATION 2 0.0011
128 INFUSION SITE DISCHARGE 2 0.0011
129 ENTEROCUTANEOUS FISTULA 1 0.0011
130 MIGRAINE WITH AURA 3 0.0011
131 AURA 2 0.0011
132 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
133 ANTIBIOTIC THERAPY 1 0.0010
134 DUST ALLERGY 1 0.0010
135 HEMIANOPIA 1 0.0010
136 BUTTERFLY RASH 1 0.0010
137 BENIGN BREAST NEOPLASM 1 0.0010
138 BREAST ABSCESS 1 0.0010
139 BONE MARROW OEDEMA 1 0.0010
140 CARPAL TUNNEL DECOMPRESSION 1 0.0009
141 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
142 GALLBLADDER ENLARGEMENT 1 0.0009
143 INCOHERENT 6 0.0009
144 INFUSION SITE BRUISING 2 0.0009
145 LISTLESS 3 0.0009
146 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
147 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
148 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
149 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
150 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
151 HYPERVENTILATION 5 0.0009
152 BRONCHIAL HYPERREACTIVITY 1 0.0008
153 CEREBRAL ARTERY EMBOLISM 1 0.0008
154 HEPATITIS 21 0.0008
155 BLOOD PHOSPHORUS DECREASED 3 0.0008
156 APPLICATION SITE BURN 4 0.0008
157 ALLERGY TO CHEMICALS 1 0.0008
158 APPLICATION SITE SWELLING 4 0.0008
159 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
160 ABNORMAL UTERINE BLEEDING 2 0.0008
161 HEAVY MENSTRUAL BLEEDING 7 0.0008
162 ADJUSTMENT DISORDER 1 0.0008
163 HIDRADENITIS 7 0.0008
164 HERPES OPHTHALMIC 1 0.0008
165 ACROCHORDON 1 0.0008
166 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
167 BODY MASS INDEX INCREASED 1 0.0007
168 SPINAL FUSION SURGERY 3 0.0007
169 CORNEAL ABRASION 1 0.0007
170 APPLICATION SITE INFLAMMATION 1 0.0007
171 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
172 THERAPEUTIC RESPONSE DELAYED 2 0.0007
173 BRONCHIAL OBSTRUCTION 1 0.0007
174 H1N1 INFLUENZA 1 0.0007
175 ALVEOLITIS 1 0.0007
176 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
177 CATAPLEXY 1 0.0007
178 CHORIORETINOPATHY 1 0.0007
179 GENITAL RASH 1 0.0007
180 SPEECH DISORDER DEVELOPMENTAL 2 0.0007
181 LIP PAIN 2 0.0007
182 EYELID PTOSIS 7 0.0007
183 LUMBAR SPINAL STENOSIS 2 0.0007
184 ANGIOPLASTY 1 0.0007
185 GASTROINTESTINAL WALL THICKENING 1 0.0007
186 ASTIGMATISM 1 0.0007
187 AGE-RELATED MACULAR DEGENERATION 1 0.0007
188 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
189 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
190 INJECTION SITE HYPERSENSITIVITY 2 0.0006
191 ENTHESOPATHY 1 0.0006
192 BACTERIAL VAGINOSIS 1 0.0006
193 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
194 STILLBIRTH 3 0.0006
195 DYSTONIA 12 0.0006
196 C-REACTIVE PROTEIN INCREASED 22 0.0006
197 GASTRIC DILATATION 1 0.0006
198 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
199 SENSATION OF FOREIGN BODY 5 0.0006
200 DEAFNESS BILATERAL 1 0.0006
201 FACIAL PARALYSIS 5 0.0006
202 BLOOD CHLORIDE INCREASED 1 0.0006
203 HYPERREFLEXIA 2 0.0006
204 EMOTIONAL POVERTY 1 0.0006
205 FANCONI SYNDROME ACQUIRED 1 0.0006
206 LOGORRHOEA 2 0.0006
207 OVERWEIGHT 3 0.0006
208 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
209 GINGIVITIS 3 0.0006
210 HYPOMANIA 2 0.0005
211 PARADOXICAL DRUG REACTION 2 0.0005
212 BODY TEMPERATURE ABNORMAL 1 0.0005
213 DENTAL CARE 1 0.0005
214 INTERMENSTRUAL BLEEDING 3 0.0005
215 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
216 BLOOD BICARBONATE DECREASED 1 0.0005
217 COLOSTOMY 1 0.0005
218 AFFECTIVE DISORDER 4 0.0005
219 DECREASED INTEREST 3 0.0005
220 ANORECTAL DISORDER 1 0.0005
221 BLEPHARITIS 2 0.0005
222 TRIGEMINAL NEURALGIA 2 0.0005
223 SEASONAL ALLERGY 7 0.0005
224 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
225 BREAST DISORDER 1 0.0005
226 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
227 ARTHRITIS BACTERIAL 2 0.0005
228 CHOLANGITIS SCLEROSING 1 0.0005
229 ANAL PRURITUS 1 0.0005
230 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
231 RENAL PAIN 5 0.0005
232 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
233 ABNORMAL SENSATION IN EYE 2 0.0005
234 TENSION HEADACHE 2 0.0005
235 BLOOD MAGNESIUM DECREASED 4 0.0005
236 HORDEOLUM 2 0.0005
237 PARONYCHIA 2 0.0005
238 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
239 PRODUCT PHYSICAL ISSUE 9 0.0004
240 CHRONIC GASTRITIS 1 0.0004
241 GASTRIC POLYPS 1 0.0004
242 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
243 ABSCESS 7 0.0004
244 INCREASED TENDENCY TO BRUISE 4 0.0004
245 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
246 BREAKTHROUGH PAIN 1 0.0004
247 GASTRITIS EROSIVE 2 0.0004
248 BILIRUBIN CONJUGATED INCREASED 1 0.0004
249 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
250 IMPAIRED WORK ABILITY 9 0.0004
251 PRE-ECLAMPSIA 2 0.0004
252 GESTATIONAL DIABETES 2 0.0004
253 VULVOVAGINAL PAIN 2 0.0004
254 NOCTURIA 5 0.0004
255 INFLAMMATORY BOWEL DISEASE 4 0.0004
256 DERMAL CYST 1 0.0004
257 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
258 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
259 HEART INJURY 1 0.0004
260 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
261 PROTEIN URINE PRESENT 2 0.0004
262 GASTROINTESTINAL TUBE INSERTION 1 0.0004
263 FLUID INTAKE REDUCED 2 0.0004
264 KLEBSIELLA INFECTION 2 0.0004
265 VULVOVAGINAL PRURITUS 2 0.0004
266 ENDODONTIC PROCEDURE 1 0.0004
267 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
268 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
269 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
270 FOOD ALLERGY 3 0.0004
271 PAIN IN JAW 11 0.0004
272 DRUG TITRATION ERROR 1 0.0004
273 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
274 FOOD CRAVING 2 0.0004
275 BLOOD LACTIC ACID INCREASED 2 0.0004
276 SCRATCH 4 0.0004
277 GINGIVAL PAIN 3 0.0004
278 ANIMAL BITE 1 0.0004
279 BLOOD POTASSIUM ABNORMAL 1 0.0004
280 AREFLEXIA 1 0.0004
281 ALCOHOL ABUSE 1 0.0004
282 ALCOHOL POISONING 1 0.0004
283 RHINITIS 3 0.0004
284 BLOOD SODIUM INCREASED 1 0.0004
285 SHOCK HAEMORRHAGIC 3 0.0004
286 BIPOLAR DISORDER 4 0.0004
287 CLUMSINESS 1 0.0004
288 SEROTONIN SYNDROME 7 0.0004
289 INTESTINAL ISCHAEMIA 2 0.0004
290 FOOT DEFORMITY 4 0.0004
291 ELECTRIC SHOCK SENSATION 1 0.0004
292 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
293 GRANULOCYTOPENIA 2 0.0004
294 PARALYSIS 5 0.0003
295 IMPAIRED QUALITY OF LIFE 5 0.0003
296 SKIN ATROPHY 2 0.0003
297 PRODUCT SUBSTITUTION ISSUE 20 0.0003
298 CARDIAC MURMUR 3 0.0003
299 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
300 FOETAL EXPOSURE DURING PREGNANCY 28 0.0003
301 RALES 2 0.0003
302 BILIARY COLIC 1 0.0003
303 GASTROINTESTINAL NECROSIS 1 0.0003
304 SINUS HEADACHE 2 0.0003
305 ATYPICAL PNEUMONIA 1 0.0003
306 CEREBROVASCULAR DISORDER 1 0.0003
307 EYE INJURY 1 0.0003
308 PERSONALITY CHANGE 3 0.0003
309 AGRANULOCYTOSIS 6 0.0003
310 FAMILY STRESS 1 0.0003
311 INFUSION SITE EXTRAVASATION 2 0.0003
312 PHOTOPHOBIA 6 0.0003
313 FOREIGN BODY IN THROAT 1 0.0003
314 BREAST CANCER RECURRENT 1 0.0003
315 PHOTOPSIA 2 0.0003
316 FAECAL CALPROTECTIN INCREASED 1 0.0003
317 THERAPEUTIC RESPONSE CHANGED 2 0.0003
318 BLADDER PAIN 1 0.0003
319 BILE DUCT STONE 1 0.0003
320 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
321 SENSORY DISTURBANCE 5 0.0003
322 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
323 HERPES SIMPLEX 2 0.0003
324 VITAMIN D DEFICIENCY 3 0.0003
325 DEAFNESS NEUROSENSORY 1 0.0003
326 DYSMENORRHOEA 4 0.0003
327 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
328 ANXIETY DISORDER 1 0.0003
329 POST-TRAUMATIC STRESS DISORDER 2 0.0003
330 DRY THROAT 3 0.0003
331 HEPATIC CYST 1 0.0003
332 SLUGGISHNESS 3 0.0003
333 IMPAIRED GASTRIC EMPTYING 4 0.0003
334 EUPHORIC MOOD 3 0.0003
335 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
336 PRESYNCOPE 7 0.0003
337 NEURALGIA 7 0.0003
338 CAROTID ARTERY STENOSIS 1 0.0003
339 HANGOVER 1 0.0003
340 COLD SWEAT 5 0.0003
341 FACIAL PARESIS 1 0.0003
342 GLOSSITIS 1 0.0003
343 HAEMORRHAGIC DIATHESIS 1 0.0003
344 FACIAL BONES FRACTURE 1 0.0003
345 APPARENT DEATH 1 0.0003
346 DISORIENTATION 11 0.0003
347 PULMONARY THROMBOSIS 3 0.0003
348 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
349 MAJOR DEPRESSION 2 0.0003
350 GASTROINTESTINAL PAIN 3 0.0003
351 BLINDNESS TRANSIENT 2 0.0003
352 URINARY RETENTION 9 0.0003
353 OCULAR DISCOMFORT 3 0.0003
354 CHRONIC SINUSITIS 1 0.0003
355 GASTRITIS 7 0.0003
356 TREATMENT FAILURE 22 0.0003
357 AUTOIMMUNE THYROIDITIS 1 0.0003
358 IMPAIRED DRIVING ABILITY 3 0.0003
359 FACE INJURY 1 0.0003
360 MICTURITION URGENCY 3 0.0003
361 HAEMODYNAMIC INSTABILITY 2 0.0003
362 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
363 INSURANCE ISSUE 4 0.0003
364 INJECTION SITE RASH 8 0.0003
365 UNDERDOSE 19 0.0003
366 MULTIPLE ALLERGIES 2 0.0003
367 CEREBRAL ATROPHY 1 0.0003
368 NECK PAIN 14 0.0003
369 CANDIDIASIS 1 0.0002
370 ENURESIS 1 0.0002
371 FRUSTRATION TOLERANCE DECREASED 2 0.0002
372 APPLICATION SITE DISCOLOURATION 1 0.0002
373 POLYURIA 2 0.0002
374 HICCUPS 2 0.0002
375 CYST 3 0.0002
376 MENSTRUAL DISORDER 2 0.0002
377 LIVE BIRTH 2 0.0002
378 HALLUCINATIONS, MIXED 1 0.0002
379 HEPATIC PAIN 1 0.0002
380 SINUSITIS 24 0.0002
381 PREMATURE BABY 7 0.0002
382 ANURIA 2 0.0002
383 BONE CANCER 1 0.0002
384 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
385 NAIL DISORDER 2 0.0002
386 IMMUNE SYSTEM DISORDER 3 0.0002
387 PRODUCT COMMUNICATION ISSUE 2 0.0002
388 ABDOMINAL ABSCESS 1 0.0002
389 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
390 EAR INFECTION 6 0.0002
391 EXPOSURE DURING PREGNANCY 14 0.0002
392 FACIAL PAIN 2 0.0002
393 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
394 GASTROINTESTINAL INFECTION 2 0.0002
395 PRODUCT TASTE ABNORMAL 3 0.0002
396 LUPUS-LIKE SYNDROME 2 0.0002
397 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
398 RESTLESS LEGS SYNDROME 4 0.0002
399 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
400 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
401 DYSPAREUNIA 1 0.0002
402 NERVE COMPRESSION 2 0.0002
403 WOUND 6 0.0002
404 FEELING OF DESPAIR 1 0.0002
405 DIARRHOEA HAEMORRHAGIC 2 0.0002
406 FLANK PAIN 2 0.0002
407 BLOOD PROLACTIN INCREASED 1 0.0002
408 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
409 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
410 SPINAL DISORDER 2 0.0002
411 FOOT FRACTURE 4 0.0002
412 PRODUCT PACKAGING ISSUE 2 0.0002
413 EYE INFLAMMATION 2 0.0002
414 ENTEROCOCCAL INFECTION 1 0.0002
415 ORAL HERPES 4 0.0002
416 DISTURBANCE IN ATTENTION 11 0.0002
417 KIDNEY INFECTION 4 0.0002
418 INJECTION SITE URTICARIA 5 0.0002
419 VITREOUS FLOATERS 2 0.0002
420 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
421 EMBEDDED DEVICE 2 0.0002
422 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
423 INABILITY TO AFFORD MEDICATION 2 0.0002
424 IMMUNODEFICIENCY 3 0.0002
425 HEPATIC ENZYME ABNORMAL 1 0.0002
426 SWELLING FACE 13 0.0002
427 HYPOAESTHESIA ORAL 3 0.0002
428 PRODUCT ADMINISTRATION ERROR 4 0.0002
429 VAGINAL DISCHARGE 2 0.0002
430 CHRONIC KIDNEY DISEASE 15 0.0002
431 CORONARY ARTERIAL STENT INSERTION 1 0.0002
432 FEEDING DISORDER 4 0.0002
433 DRUG LEVEL DECREASED 2 0.0002
434 EPILEPSY 6 0.0002
435 TEMPERATURE INTOLERANCE 2 0.0002
436 TENDONITIS 3 0.0002
437 THERAPY PARTIAL RESPONDER 3 0.0002
438 RESPIRATORY TRACT INFECTION 5 0.0002
439 PRODUCT ODOUR ABNORMAL 2 0.0002
440 INJECTION SITE DISCOMFORT 2 0.0002
441 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
442 JOINT DISLOCATION 2 0.0002
443 HALLUCINATION, AUDITORY 3 0.0002
444 SCIATICA 3 0.0002
445 JOINT INJURY 4 0.0002
446 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
447 FOOD POISONING 1 0.0002
448 COMPRESSION FRACTURE 1 0.0002
449 ANAL FISSURE 1 0.0002
450 HEREDITARY ANGIOEDEMA 2 0.0002
451 SUICIDAL IDEATION 17 0.0002
452 ANAL ABSCESS 1 0.0002
453 PRURITUS GENERALISED 4 0.0002
454 THROAT TIGHTNESS 5 0.0002
455 PHARYNGITIS STREPTOCOCCAL 2 0.0002
456 BLOOD POTASSIUM INCREASED 3 0.0002
457 ERYTHEMA OF EYELID 1 0.0002
458 BACK DISORDER 3 0.0002
459 SKIN LACERATION 2 0.0002
460 FAECALOMA 1 0.0002
461 DEAFNESS UNILATERAL 1 0.0002
462 PROCEDURAL PAIN 5 0.0002
463 FUNGAL INFECTION 6 0.0002
464 LEUKOPENIA 9 0.0002
465 TOOTH DISORDER 4 0.0002
466 NERVE INJURY 2 0.0002
467 HYPERTENSIVE CRISIS 2 0.0002
468 INJECTION SITE PRURITUS 12 0.0002
469 AGITATION 13 0.0002
470 CHOLECYSTITIS ACUTE 1 0.0002
471 GENERALISED ERYTHEMA 1 0.0002
472 CARDIAC VALVE DISEASE 1 0.0002
473 NEPHROLITHIASIS 8 0.0002
474 INFLAMMATION 9 0.0002
475 TINNITUS 8 0.0002
476 PARANOIA 3 0.0002
477 NIGHTMARE 6 0.0002
478 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
479 CAESAREAN SECTION 2 0.0002
480 VASCULITIS 2 0.0002
481 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
482 OSTEOPOROSIS 7 0.0002
483 COVID-19 PNEUMONIA 2 0.0002
484 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
485 BLOOD IRON DECREASED 2 0.0002
486 CATARACT OPERATION 1 0.0002
487 CATARACT 10 0.0002
488 THIRST 3 0.0002
489 ACCIDENT 2 0.0002
490 WITHDRAWAL SYNDROME 7 0.0002
491 COMPLICATION OF DEVICE REMOVAL 3 0.0002
492 PARAESTHESIA 26 0.0002
493 DRUG EFFECT INCOMPLETE 6 0.0002
494 PELVIC PAIN 3 0.0002
495 CRYING 6 0.0002
496 SUICIDE ATTEMPT 10 0.0002
497 BURSITIS 2 0.0002
498 FIBROMYALGIA 4 0.0002
499 DERMATITIS ACNEIFORM 1 0.0002
500 INJECTION SITE BRUISING 13 0.0002
501 ENCEPHALOPATHY 4 0.0002
502 MUSCLE SPASTICITY 2 0.0002
503 INJECTION SITE MASS 6 0.0002
504 INJECTION SITE EXTRAVASATION 2 0.0002
505 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
506 GENERALISED OEDEMA 2 0.0002
507 DYSGEUSIA 12 0.0002
508 THINKING ABNORMAL 3 0.0002
509 BACTERIAL INFECTION 3 0.0002
510 MIDDLE INSOMNIA 3 0.0002
511 CONSTIPATION 35 0.0002
512 INJECTION SITE REACTION 11 0.0002
513 FEELING ABNORMAL 38 0.0002
514 BRAIN OEDEMA 2 0.0002
515 BLOOD URINE PRESENT 3 0.0002
516 HEADACHE 99 0.0002
517 SLEEP APNOEA SYNDROME 3 0.0002
518 INJECTION SITE IRRITATION 2 0.0002
519 HYPOPHAGIA 4 0.0002
520 THERAPY NON-RESPONDER 7 0.0002
521 UNRESPONSIVE TO STIMULI 4 0.0002
522 CONFUSIONAL STATE 25 0.0002
523 RASH GENERALISED 4 0.0002
524 EAR PAIN 3 0.0002
525 APPLICATION SITE VESICLES 1 0.0002
526 DIPLOPIA 4 0.0002
527 HAEMORRHOIDS 3 0.0002
528 DEAFNESS 4 0.0002
529 SKIN IRRITATION 7 0.0002
530 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
531 IMPAIRED HEALING 5 0.0002
532 ORAL CANDIDIASIS 2 0.0002
533 PULMONARY CONGESTION 2 0.0002
534 SINUS DISORDER 3 0.0002
535 HAEMATOCRIT DECREASED 3 0.0002
536 CORONAVIRUS INFECTION 1 0.0002
537 CHEST PAIN 28 0.0002
538 ANXIETY 43 0.0002
539 BLOOD PRESSURE ABNORMAL 3 0.0002
540 BALANCE DISORDER 13 0.0002
541 SYNCOPE 15 0.0001
542 SPINAL FRACTURE 3 0.0001
543 GAIT INABILITY 5 0.0001
544 CHOLECYSTITIS CHRONIC 1 0.0001
545 MENSTRUATION IRREGULAR 4 0.0001
546 QUALITY OF LIFE DECREASED 2 0.0001
547 BRONCHITIS 11 0.0001
548 COLITIS ISCHAEMIC 1 0.0001
549 SINUS CONGESTION 2 0.0001
550 ANGER 5 0.0001
551 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
552 INJURY ASSOCIATED WITH DEVICE 3 0.0001
553 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
554 MYALGIA 25 0.0001
555 ABNORMAL LOSS OF WEIGHT 1 0.0001
556 MOOD ALTERED 4 0.0001
557 MULTIPLE SCLEROSIS 7 0.0001
558 ACUTE HEPATIC FAILURE 2 0.0001
559 PERIPHERAL COLDNESS 2 0.0001
560 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
561 APPLICATION SITE RASH 2 0.0001
562 RESPIRATORY ARREST 4 0.0001
563 DEPRESSION 33 0.0001
564 DIVERTICULITIS 4 0.0001
565 RASH MACULAR 5 0.0001
566 COVID-19 25 0.0001
567 DUODENAL ULCER 1 0.0001
568 FLATULENCE 8 0.0001
569 ABDOMINAL PAIN UPPER 29 0.0001
570 RETCHING 3 0.0001
571 OROPHARYNGEAL PAIN 13 0.0001
572 DRUG INEFFECTIVE 185 0.0001
573 INTENTIONAL OVERDOSE 9 0.0001
574 INTENTIONAL DOSE OMISSION 4 0.0001
575 DRY EYE 7 0.0001
576 BRONCHOSPASM 2 0.0001
577 HYPERSENSITIVITY 26 0.0001
578 ARTHRITIS 11 0.0001
579 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
580 NAUSEA 110 0.0001
581 PYREXIA 48 0.0001
582 PRODUCT DOSE OMISSION 9 0.0001
583 PANIC ATTACK 5 0.0001
584 APATHY 2 0.0001
585 APPLICATION SITE PAIN 3 0.0001
586 CEREBRAL DISORDER 1 0.0001
587 CONTUSION 13 0.0001
588 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
589 ARTHROPOD BITE 1 0.0001
590 ABDOMINAL DISTENSION 14 0.0001
591 RASH PAPULAR 3 0.0001
592 GENERAL SYMPTOM 1 0.0001
593 BLOOD POTASSIUM DECREASED 4 0.0001
594 DERMATITIS ATOPIC 7 0.0001
595 DIZZINESS 66 0.0001
596 COLITIS 5 0.0001
597 OSTEOPENIA 2 0.0001
598 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
599 DISSOCIATION 1 0.0001
600 MUSCULOSKELETAL CHEST PAIN 2 0.0001
601 CONCUSSION 1 0.0001
602 INJECTION SITE ERYTHEMA 16 0.0001
603 APHTHOUS ULCER 1 0.0001
604 NERVOUS SYSTEM DISORDER 4 0.0001
605 GASTROINTESTINAL INFLAMMATION 1 0.0001
606 VOMITING 60 0.0001
607 BRAIN FOG 2 0.0001
608 DRUG-INDUCED LIVER INJURY 4 0.0001
609 DRUG SCREEN POSITIVE 1 0.0001
610 FURUNCLE 1 0.0001
611 DISEASE RECURRENCE 6 0.0001
612 BLOOD ALBUMIN DECREASED 1 0.0001
613 ARTHROPATHY 7 0.0001
614 MOOD SWINGS 4 0.0001
615 INJECTION SITE HAEMORRHAGE 10 0.0001
616 BLOOD DISORDER 1 0.0001
617 MOVEMENT DISORDER 4 0.0001
618 SOMNOLENCE 25 0.0001
619 INSOMNIA 33 0.0001
620 MUSCLE TIGHTNESS 2 0.0001
621 URINARY TRACT INFECTION 21 0.0001
622 ABNORMAL FAECES 1 0.0001
623 CHOLELITHIASIS 4 0.0001
624 MULTIPLE FRACTURES 2 0.0001
625 ESCHERICHIA INFECTION 1 0.0001
626 HAIR DISORDER 1 0.0001
627 OSTEONECROSIS OF JAW 3 0.0001
628 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
629 ACUTE CORONARY SYNDROME 1 0.0001
630 TREMOR 20 0.0001
631 VIRAL INFECTION 4 0.0001
632 LIP SWELLING 4 0.0001
633 EOSINOPHIL COUNT INCREASED 1 0.0001
634 POLLAKIURIA 5 0.0001
635 PALPITATIONS 14 0.0001
636 ATRIAL SEPTAL DEFECT 1 0.0001
637 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
638 HAEMATEMESIS 3 0.0001
639 SWELLING 11 0.0001
640 INJECTION SITE SWELLING 9 0.0001
641 THERAPY CESSATION 6 0.0001
642 GASTRIC DISORDER 4 0.0001
643 VISION BLURRED 16 0.0001
644 MUSCULOSKELETAL DISCOMFORT 2 0.0001
645 EXPOSURE VIA SKIN CONTACT 3 0.0001
646 SEPTIC SHOCK 5 0.0001
647 DISCOMFORT 7 0.0001
648 SEDATION 3 0.0001
649 HYPERKALAEMIA 4 0.0001
650 GROIN PAIN 1 0.0001
651 GRIP STRENGTH DECREASED 1 0.0001
652 DEPRESSED MOOD 6 0.0001
653 SLEEP DISORDER 8 0.0001
654 HEAD DISCOMFORT 2 0.0001
655 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
656 BREAST CANCER FEMALE 3 0.0001
657 ABDOMINAL PAIN 26 0.0001
658 THROAT IRRITATION 5 0.0001
659 INJECTION SITE PAIN 34 0.0001
660 LIMB INJURY 3 0.0001
661 INFLUENZA LIKE ILLNESS 9 0.0001
662 MUSCLE SPASMS 20 0.0001
663 DYSURIA 4 0.0001
664 GRAND MAL CONVULSION 1 0.0001
665 CONJUNCTIVITIS 2 0.0001
666 URTICARIA 18 0.0001
667 ABDOMINAL DISCOMFORT 18 0.0001
668 APPENDICITIS 1 0.0001
669 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
670 INTESTINAL OBSTRUCTION 4 0.0001
671 BLOOD SODIUM DECREASED 2 0.0001
672 DYSPHAGIA 10 0.0001
673 PROTEINURIA 2 0.0001
674 MUSCULOSKELETAL DISORDER 2 0.0001
675 COMA 5 0.0001
676 CONVULSION 6 0.0001
677 ANGINA PECTORIS 3 0.0001
678 INCREASED APPETITE 2 0.0001
679 HERPES ZOSTER 6 0.0001
680 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
681 POST PROCEDURAL COMPLICATION 2 0.0001
682 ACUTE RESPIRATORY FAILURE 2 0.0001
683 AFFECT LABILITY 1 0.0001
684 MUSCULOSKELETAL STIFFNESS 9 0.0001
685 AUTOIMMUNE DISORDER 1 0.0001
686 NASAL CONGESTION 6 0.0001
687 CONDITION AGGRAVATED 31 0.0001
688 COELIAC DISEASE 1 0.0001
689 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
690 UPPER LIMB FRACTURE 2 0.0001
691 ABORTION SPONTANEOUS 4 0.0001
692 IRRITABILITY 6 0.0001
693 HYPERTENSION 21 0.0001
694 INFLUENZA 11 0.0001
695 PSORIATIC ARTHROPATHY 4 0.0001
696 VERTIGO 6 0.0001
697 FLUSHING 10 0.0001
698 FLUID RETENTION 5 0.0001
699 EAR DISCOMFORT 1 0.0001
700 PRODUCT PREPARATION ERROR 2 0.0001
701 RIB FRACTURE 2 0.0001
702 RHEUMATOID ARTHRITIS 11 0.0001
703 PULMONARY HYPERTENSION 2 0.0001
704 MALAISE 42 0.0001
705 NERVOUSNESS 5 0.0001
706 INTENTIONAL DRUG MISUSE 2 0.0001
707 HAEMORRHAGE 10 0.0001
708 ROAD TRAFFIC ACCIDENT 4 0.0001
709 DERMATITIS 2 0.0001
710 MUSCULOSKELETAL PAIN 5 0.0001
711 SPEECH DISORDER 5 0.0001
712 FULL BLOOD COUNT ABNORMAL 1 0.0001
713 DIARRHOEA 61 0.0001
714 OSTEOARTHRITIS 4 0.0001
715 BREAST PAIN 1 0.0001
716 BODY HEIGHT DECREASED 1 0.0001
717 IRRITABLE BOWEL SYNDROME 2 0.0001
718 BREAST CANCER METASTATIC 1 0.0001
719 POOR QUALITY SLEEP 2 0.0001
720 DRUG EFFECT DECREASED 5 0.0001
721 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
722 FAECES DISCOLOURED 2 0.0001
723 BACK INJURY 1 0.0001
724 PRODUCT DISPENSING ERROR 2 0.0001
725 PRODUCT PRESCRIBING ISSUE 2 0.0001
726 RASH 40 0.0001
727 OSTEONECROSIS 3 0.0001
728 EYE DISORDER 3 0.0001
729 STAPHYLOCOCCAL INFECTION 3 0.0001
730 INFUSION RELATED REACTION 6 0.0001
731 DENTAL CARIES 1 0.0001
732 VISUAL ACUITY REDUCED 3 0.0001
733 FATIGUE 70 0.0001
734 HYPOTENSION 18 0.0001
735 SNEEZING 2 0.0001
736 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
737 ARTHRALGIA 37 0.0001
738 PANCREATITIS ACUTE 2 0.0001
739 OXYGEN SATURATION DECREASED 5 0.0001
740 FISTULA 1 0.0001
741 BLOOD CALCIUM DECREASED 1 0.0001
742 EYE INFECTION 1 0.0001
743 APPLICATION SITE PRURITUS 2 0.0001
744 CHOLECYSTECTOMY 1 0.0001
745 SKIN DISCOLOURATION 4 0.0001
746 HYPOAESTHESIA 13 0.0001
747 MUSCLE TWITCHING 2 0.0001
748 DRY MOUTH 7 0.0001
749 BACK PAIN 20 0.0001
750 LOSS OF CONSCIOUSNESS 11 0.0001
751 DYSPHONIA 5 0.0001
752 HEART RATE DECREASED 3 0.0001
753 HYPERHIDROSIS 11 0.0001
754 DEVICE MALFUNCTION 6 0.0001
755 BONE PAIN 5 0.0001
756 PRODUCT USE ISSUE 16 0.0001
757 WEIGHT INCREASED 19 0.0001
758 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
759 PAIN 52 0.0001
760 ARRHYTHMIA 4 0.0001
761 WHEEZING 5 0.0001
762 ATAXIA 1 0.0001
763 PRODUCT PRESCRIBING ERROR 2 0.0001
764 THERAPY INTERRUPTED 6 0.0001
765 CEREBRAL HAEMORRHAGE 3 0.0001
766 SKIN BURNING SENSATION 6 0.0001
767 EMOTIONAL DISTRESS 10 0.0001
768 THERAPEUTIC RESPONSE DECREASED 5 0.0001
769 ADRENAL INSUFFICIENCY 1 0.0001
770 RESTLESSNESS 3 0.0001
771 LUNG DISORDER 4 0.0001
772 ALOPECIA 16 0.0001
773 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
774 DYSPEPSIA 8 0.0001
775 HEART RATE INCREASED 8 0.0001
776 SEPSIS 9 0.0001
777 EYE SWELLING 3 0.0001
778 EXTRAPYRAMIDAL DISORDER 2 0.0001
779 HAIR COLOUR CHANGES 1 0.0001
780 AGEUSIA 2 0.0001
781 MEMORY IMPAIRMENT 11 0.0001
782 INTENTIONAL PRODUCT MISUSE 7 0.0001
783 DRUG WITHDRAWAL SYNDROME 7 0.0001
784 DYSARTHRIA 3 0.0001
785 DYSPNOEA EXERTIONAL 3 0.0001
786 DERMATITIS ALLERGIC 1 0.0001
787 OVERDOSE 17 0.0001
788 TACHYCARDIA 7 0.0001
789 DEVICE DEPLOYMENT ISSUE 1 0.0001
790 GASTROINTESTINAL DISORDER 7 0.0001
791 FALL 26 0.0001
792 PAIN IN EXTREMITY 23 0.0001
793 DEVICE ISSUE 7 0.0001
794 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
795 ILLNESS 8 0.0001
796 RHINORRHOEA 5 0.0001
797 HIATUS HERNIA 1 0.0001
798 HAEMATOMA 2 0.0001
799 AMNESIA 5 0.0001
800 APPLICATION SITE ERYTHEMA 2 0.0001
801 ANHEDONIA 2 0.0001
802 NASOPHARYNGITIS 14 0.0001
803 ANKYLOSING SPONDYLITIS 1 0.0001
804 DEVICE DIFFICULT TO USE 5 0.0001
805 WEIGHT DECREASED 21 0.0001
806 EYE HAEMORRHAGE 1 0.0001
807 COUGH 21 0.0001
808 PRODUCT DOSE OMISSION ISSUE 22 0.0001
809 HAIR TEXTURE ABNORMAL 1 0.0001
810 BLOOD BILIRUBIN INCREASED 2 0.0001
811 DEVICE BREAKAGE 3 0.0001
812 RASH PRURITIC 4 0.0001
813 HEPATIC ENZYME INCREASED 5 0.0001
814 AKATHISIA 1 0.0001
815 VISUAL IMPAIRMENT 9 0.0001
816 DRUG INTOLERANCE 7 0.0001
817 ABNORMAL DREAMS 2 0.0001
818 ANAPHYLACTIC REACTION 4 0.0001
819 DRUG ABUSE 6 0.0001
820 MENTAL STATUS CHANGES 2 0.0001
821 OFF LABEL USE 63 0.0001
822 BLOOD PRESSURE INCREASED 11 0.0001
823 APHONIA 1 0.0001
824 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
825 BLINDNESS UNILATERAL 1 0.0001
826 EYE PAIN 4 0.0001
827 ASTHMA 8 0.0001
828 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
829 MUSCULAR WEAKNESS 8 0.0001
830 ACCIDENTAL UNDERDOSE 1 0.0001
831 DEVICE LEAKAGE 3 0.0001
832 ASTHENIA 26 0.0001
833 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
834 ANOSMIA 1 0.0001
835 DEVICE DISLOCATION 3 0.0001
836 MENTAL DISORDER 3 0.0001
837 DYSPNOEA 39 0.0001
838 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
839 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
840 CHILLS 8 0.0001
841 PSYCHOTIC DISORDER 2 0.0001
842 LIVER DISORDER 3 0.0001
843 RESPIRATORY DISORDER 2 0.0001
844 BONE LOSS 1 0.0001
845 HOT FLUSH 5 0.0001
846 APHASIA 2 0.0001
847 LACRIMATION INCREASED 2 0.0001
848 ECONOMIC PROBLEM 1 0.0001
849 INCORRECT DOSE ADMINISTERED 15 0.0001
850 DEVICE ADHESION ISSUE 1 0.0001
851 HOSPITALISATION 10 0.0001
852 DECREASED APPETITE 15 0.0001
853 COGNITIVE DISORDER 3 0.0001
854 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
855 BASAL CELL CARCINOMA 1 0.0001
856 DRUG DOSE OMISSION BY DEVICE 5 0.0001
857 BONE DENSITY DECREASED 2 0.0001
858 CYANOSIS 1 0.0001
859 RASH ERYTHEMATOUS 3 0.0001
860 BLOOD GLUCOSE DECREASED 3 0.0001
861 NIGHT SWEATS 2 0.0001
862 CARDIAC ARREST 5 0.0001
863 DRUG DOSE OMISSION 10 0.0001
864 DEHYDRATION 8 0.0001
865 SKIN DISORDER 2 0.0001
866 BLOOD UREA INCREASED 1 0.0001
867 FACE OEDEMA 1 0.0001
868 CANDIDA INFECTION 1 0.0001
869 HEMIPARESIS 1 0.0001
870 CIRCULATORY COLLAPSE 1 0.0001
871 CHEST DISCOMFORT 6 0.0001
872 HAEMATURIA 2 0.0001
873 DEVICE DEFECTIVE 1 0.0001
874 ANAEMIA 11 0.0001
875 GAIT DISTURBANCE 11 0.0001
876 OEDEMA PERIPHERAL 7 0.0001
877 PRURITUS 22 0.0001
878 EOSINOPHILIA 1 0.0001
879 BURNING SENSATION 4 0.0001
880 LYMPHADENOPATHY 2 0.0001
881 PRODUCT ADHESION ISSUE 2 0.0001
882 DRUG DEPENDENCE 9 0.0001
883 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
884 GOUT 1 0.0001
885 MOBILITY DECREASED 4 0.0001
886 ADVERSE DRUG REACTION 5 0.0001
887 GASTROENTERITIS VIRAL 1 0.0001
888 HYPERGLYCAEMIA 2 0.0001
889 RESPIRATORY FAILURE 4 0.0001
890 END STAGE RENAL DISEASE 1 0.0001
891 ACCIDENTAL OVERDOSE 2 0.0001
892 HAEMATOCHEZIA 3 0.0001
893 MEDICATION ERROR 3 0.0001
894 THROMBOCYTOPENIA 6 0.0001
895 ERYTHEMA 11 0.0001
896 HEPATIC CIRRHOSIS 1 0.0001
897 FRACTURE 1 0.0001
898 NEUROPATHY PERIPHERAL 5 0.0001
899 ACUTE KIDNEY INJURY 8 0.0001
900 CHOLESTASIS 1 0.0001
901 SEIZURE 6 0.0001
902 PERIPHERAL SWELLING 8 0.0001
903 ERUCTATION 1 0.0001
904 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
905 CHOKING 1 0.0001
906 SURGERY 3 0.0001
907 DISABILITY 1 0.0001
908 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
909 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
910 DRUG INTERACTION 8 0.0001
911 JOINT SWELLING 6 0.0000
912 FULL BLOOD COUNT DECREASED 1 0.0000
913 BODY TEMPERATURE INCREASED 1 0.0000
914 FEELING HOT 3 0.0000
915 INFECTION 7 0.0000
916 CARDIO-RESPIRATORY ARREST 2 0.0000
917 SKIN EXFOLIATION 4 0.0000
918 EATING DISORDER 1 0.0000
919 PNEUMONIA 15 0.0000
920 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
921 PSORIASIS 6 0.0000
922 PRODUCT STORAGE ERROR 4 0.0000
923 ANGIOEDEMA 2 0.0000
924 COLITIS ULCERATIVE 2 0.0000
925 GLOSSODYNIA 1 0.0000
926 PRODUCT QUALITY ISSUE 6 0.0000
927 RENAL DISORDER 2 0.0000
928 BLOOD CHOLESTEROL INCREASED 2 0.0000
929 OCULAR HYPERAEMIA 2 0.0000
930 PULMONARY EMBOLISM 4 0.0000
931 BLOOD PRESSURE FLUCTUATION 1 0.0000
932 ATRIAL FIBRILLATION 4 0.0000
933 MYOCARDIAL INFARCTION 7 0.0000
934 HALLUCINATION 3 0.0000
935 CELLULITIS 2 0.0000
936 ABDOMINAL PAIN LOWER 1 0.0000
937 HAEMOGLOBIN DECREASED 4 0.0000
938 ANAPHYLACTIC SHOCK 1 0.0000
939 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
940 THROMBOSIS 3 0.0000
941 FEAR 1 0.0000
942 FREQUENT BOWEL MOVEMENTS 1 0.0000
943 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
944 OEDEMA 2 0.0000
945 FEELING COLD 1 0.0000
946 LETHARGY 2 0.0000
947 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
948 HEPATIC FAILURE 1 0.0000
949 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
950 ILL-DEFINED DISORDER 2 0.0000
951 ADVERSE EVENT 3 0.0000
952 BREAST CANCER 3 0.0000
953 HEAD INJURY 1 0.0000
954 CYSTITIS 1 0.0000
955 HIP FRACTURE 1 0.0000
956 FEBRILE NEUTROPENIA 2 0.0000
957 RENAL FAILURE 4 0.0000
958 NEOPLASM MALIGNANT 2 0.0000
959 TOXICITY TO VARIOUS AGENTS 5 0.0000
960 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
961 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
962 DEVICE USE ERROR 1 0.0000
963 INJURY 2 0.0000
964 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
965 UNEVALUABLE EVENT 2 0.0000
966 ACNE 2 0.0000
967 ABNORMAL BEHAVIOUR 1 0.0000
968 EXTRA DOSE ADMINISTERED 1 0.0000
969 DYSKINESIA 1 0.0000
970 BLINDNESS 1 0.0000
971 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
972 CEREBROVASCULAR ACCIDENT 4 0.0000
973 DRY SKIN 3 0.0000
974 NEUTROPENIA 3 0.0000
975 CARDIAC DISORDER 2 0.0000
976 COLORECTAL CANCER 1 0.0000
977 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
978 PLATELET COUNT DECREASED 2 0.0000
979 BLISTER 1 0.0000
980 EYE IRRITATION 1 0.0000
981 DEVICE EXPULSION 1 0.0000
982 BLOOD PRESSURE DECREASED 1 0.0000
983 EPISTAXIS 1 0.0000
984 DIABETES MELLITUS 1 0.0000
985 CARDIAC FAILURE 1 0.0000
986 COMPLETED SUICIDE 1 0.0000
987 NO ADVERSE EVENT 2 0.0000
988 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
989 DISEASE PROGRESSION 1 0.0000
990 BLOOD GLUCOSE INCREASED 1 0.0000
991 DEATH 4 0.0000